It's a Tale of Ticking Clocks and Risky Endeavors
The bubble baby treatment, Orchard and CIRM's future
Somewhat lost in the recent news about UCLA’s “bubble baby” gene therapy cure is the current state of affairs at the London company that abandoned the treatment nearly two years ago.
The firm is Orchard Therapeutics PLC, a publicly traded enterprise that was founded in 2015. One of its foundational products was to be a gene therapy for A…
